United States · 
Who invested in Rezo Therapeutics?
Rezo Therapeutics's investors include Andreessen Horowitz, SV Angel, Norwest Venture Partners, Liquid 2 Ventures and Eli Lilly.
United States · Series A startup
Who invested in Rezo Therapeutics
Funding summaryUpdated 26 Oct 2026
$78Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $78MNov 2022
- Investors
- 5
The rounds
- Nov 2022Series A$78M
Source recordedSEC filing: $15M sold, first sale Jul 2022
Founders and team
From Rezo Therapeutics's own website: 1 founder, 7 on the team.
Peggy AckerbergExecutive Assistant to Co-Founder
- Derek HicksChief Executive Officer
- Jake WilliamsVice President of Business Development and Strategy
- Amy KendallSenior Director of Administration
- David YuResearch Associate II, Drug Discovery Technical Operations
- Elena LeonDirector of Program Management
- Matthew R. PattersonBoard Chairman
- Todd DaigleAssociate Director of Facilities & Operations
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Rezo Therapeutics
How much has Rezo Therapeutics raised?
Rezo Therapeutics has raised $78M across 1 round since 2022.
When did Rezo Therapeutics last raise?
Rezo Therapeutics's most recent round was a Series A of $78M in Nov 2022.
What was Rezo Therapeutics's biggest round?
Its most recent round, $78M in Nov 2022, is also its largest on record.
Who backed Rezo Therapeutics first?
Rezo Therapeutics's first round on record, in Nov 2022, was backed by Andreessen Horowitz, SV Angel and Norwest Venture Partners and 2 others.
What stage is Rezo Therapeutics at?
Rezo Therapeutics's latest named round is a Series A, in Nov 2022.
Where is Rezo Therapeutics based?
Rezo Therapeutics is based in the United States.
Companies like Rezo Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.